Sunway Microbiome Centre

Sunway Microbiome Centre

SUMS

 

Overview

Sunway Microbiome Centre focuses primarily on the research of microbiota in health and disease. We collaborate nationally and internationally with researchers across multiple disciplines to advance microbiome research to unravel how naturally existing microbial species in the digestive system influence the occurrence and progression of a variety of human illnesses and diseases.

Vision

To be a globally recognized leader in microbiome research and innovation for the advancement of scientific knowledge and human health and sustainable development.

Mission

To conduct world-class microbiome research and innovation that brings value and benefit to industry and society.

To achieve its vision and mission, the centre is committed towards: 

Advanced Research 
To unravel the complex microbiome-host-environment interactions. 

Education
To train and nurture a new generation of scientists and researchers specializing in cutting-edge microbiome research. 

Practical Applications
To translate research findings into practical applications, therapies, and interventions for improving human health, supporting relevant industries, and enhancing sustainable development. 

Collaboration
To foster local and global interdisciplinary collaborations and partnerships to accelerate knowledge sharing, advancement, and translation of knowledge in microbiome. 

Knowledge Exchange
To function as a hub for knowledge exchange, public engagement, and policy development related to the microbiome.

Research (ongoing)

  • Understanding the molecular determinants of virulence and antigenicity of pathogenic viruses, namely enterovirus 71 (EV-A71) and dengue virus
  • Understanding the immune responses of viral pathogens to novel vaccines — synthetic peptide-based and live attenuated  
  • Designing anti-viral strategies, namely antivirals and antiviral peptides against EV-A71 and dengue
  • Exploring the future development of therapeutics based on microRNAs in viral and bacterial diseases
  • Advancing the development of DNA vaccines against antibiotic resistant bacteria